Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined metformin and sitagliptin effect on insulin resistance–related protein expression in adipose tissue of type 2 diabetic patients
IRCT20171018036870N2Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of metformin and sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Expression levels of proteins involved in insulin resistance in adipose tissue. Started Feb 2018; status: completed.
02
Drugs
metforminsitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20171018036870N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171018036870N2.